UK markets closed

CompuGroup Medical SE & Co. KGaA (CMPUY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
89.650.00 (0.00%)
At close: 10:33AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close89.65
Open89.65
BidN/A x N/A
AskN/A x N/A
Day's range89.65 - 89.65
52-week range70.75 - 89.65
Volume100
Avg. volume1
Market capN/A
Beta (5Y monthly)0.82
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM19.05.2021 / 13:46 The issuer is solely responsible for the content of this announcement.Koblenz. CompuGroup Medical SE & Co. KGaA - one of the leading e-health companies in the world - today successfully held its virtual Annual General Meeting (AGM). The resolutions on the dividend payment, the purchase and use of treasury shares, the remuneration system and the discharge of the executive and supervisory boards were passed with convincing majorities. The management confirmed the guidance for the current year and mid-term growth targets.The attendance at today's AGM, which was held as a virtual meeting for the second time due to the ongoing COVID-19 pandemic, was about 83 % of total share capital. The resolution on the appropriation of profits including the proposed dividend of EUR 0.50 was passed with a majority of 99.9 %. The AGM also passed resolutions on the approval of the actions of the former Management Board, the current General Partner and the former and the current Supervisory Boards, the purchase and use of treasury shares and the remuneration system for the Managing Directors and Supervisory Board, each with convincing majorities of more than 75 % of the votes."CompuGroup Medical achieved record revenues of EUR 837 million in the financial year 2020 - a remarkable increase of 12 %. At the same time, the adjusted EBITDA increased by 8 % to EUR 215 million," said CEO Dr. Dirk Wössner and added, "Worldwide, the COVID-19 pandemic has proven in a dramatic way how crucial well-functioning, efficient healthcare is, and which opportunities arise from digitization of the processes, data processing and information exchange. Many governments have recognized the urgent need for action and have set up large investment programs in the billions, in some cases."In his speech, Dirk Wössner confirmed the guidance for the current financial year, envisaging more than EUR 1 billion in revenues and an adjusted EBITDA in the range of EUR 210 - 230 million. And he emphasized that CGM is targeting significant growth in the future from enhancing services for healthcare professionals with new functionalities, patient portals, synergies and scale effects from the two large acquisitions in the hospital business and the US market, from additional modules in Telematics Infrastructure, new data services and by digitization initiatives such as the Hospital Future Act in Germany.Dirk Wössner: "Beyond 2021, we expect annual organic revenue growth of 5 % and more with the EBITDA margin increasing again at the same time."Information on the AGM including the full voting results is available at www.cgm.com/agm.About CompuGroup Medical SE & Co. KGaACompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among e-health service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.Contact for media representatives:Michael FranzHead of Brand CommunicationP +49 (0) 261 8000-6100F +49 (0) 261 8000-3100E-mail: press@cgm.comContact for analysts and investors:Claudia ThoméCorporate Vice President Investor RelationsP +49 (0) 261 8000-7030F +49 (0) 261 8000-3200E-mail: claudia.thome@cgm.com19.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 7030 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1198437 End of News DGAP News Service

  • EQS Group

    Universitätsklinik Hamburg-Eppendorf (UKE) decides for a future with CGM CLINICAL

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous15.04.2021 / 09:05 The issuer is solely responsible for the content of this announcement.Koblenz. CompuGroup Medical (CGM), one of the world's leading providers of e-health solutions, announced today that the medical center Universitätsklinik Hamburg-Eppendorf (UKE), one of Europe's leading university clinics, selected the CGM CLINICAL hospital information system as the core enterprise-wide electronic health record (EHR) system. For more than a decade, UKE has been a pioneer in digitization of healthcare and is now taking the next step by choosing an innovative partner. Using cutting-edge features will further propel UKE's experience in case as part of an integrated patient journey. UKE is one of Europe's highly reputable clinics with more than 13,500 employees. It is characterized by state-of-the-art medical technology, innovative information technology (UKE has been certified as Europe's first fully digital hospital), and architecture created with the goal of medical excellence, all patient-centric and with set up to optimally supporting doctors, nursing staff, and therapists. At the UKE clinic, healthcare and research go hand in hand, which is impressively shown by the research results achieved in the recent months - in parallel to patient care - on the Corona Virus.CGM prevailed among many other competitors in a two-year award process and was awarded the contract. UKE will use the entire spectrum of CGM CLINICAL medical modules, based on the CGM CLNICAL data model CDM+ which is highly structured, yet open and flexible. This will enable numerous new ways of using data for both research and excellent care."At UKE, we are dedicated to delivering care with an understanding of the whole patient journey," said Professor Christian Gerloff, Vice Medical Director of UKE, "We are convinced that CGM is the perfect partner for a healthcare organization like us, and that CGM CLINICAL can enable all our healthcare professionals to deliver excellent and integrated care based on cutting-edge technology."Marco Siebener, CIO of UKE, added, "Coming from a very high standard of digitization already, we now want to achieve the next level. Therefore, we must tackle challenges in fields of personalized medicine, smart data, real-time analytics and clinical decision support, as well as effective connectivity across sectors with patients and colleagues. Together with CGM, we see the potential for game-changing approaches.""The largest order for our cutting-edge G3 platform in Germany - and the second largest in this segment - from one of the best university clinics in Europe confirms our strategy. Our investments into G3 are thus paying off," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical, "We are proud to support one of the European leaders in medical excellence and digitization in healthcare with our innovative CGM CLINICAL solutions."Hannes Reichl, Managing Director Inpatient and Social Care at CGM, added, "UKE's decision marks another major milestone in the rollout of CGM CLINICAL and once more proofs its innovative strength. This state-of-the-art product will enable UKE to enhance its processes, which are already digitized along the entire patient journey, even more flexibly and precisely fitting the requirements of a dynamic university clinic. CDM+ data model will thus strengthen communication and connectivity within UKE's facilities, but also with healthcare providers in other clinical or ambulatory institutions."The partners agreed to start the project in May 2021, with a duration of 4 years. There will be a step-by-step rollout across UKE, with the common goal of a first rollout in 2022. The implementation will start in the UKE's Martini Clinic, a highly specialized prostate Cancer Center, and the University Heart & Vascular Center, both in entirely new buildings.About UKESince its foundation in 1889, the Medical Center Hamburg-Eppendorf (UKE) has been one of the leading clinics in Europe. With about 13,600 employees, the UKE is one of the largest employer in the Free and Hanseatic City of Hamburg. The UKE treats about 511,000 patients a year, 106,000 of whom are inpatients and 405,000 are outpatients. The emphasis in UKE's research are the neurosciences, cardio-vascular research, care research, oncology, as well as infections and inflammations. Other potential areas of the UKE are molecular imaging and skeletal biology research. The UKE educates about 3,400 medical specialists and dentists.Knowledge, Research, Healing through Shared Competence: The UKE | www.uke.de About CompuGroup Medical SE & Co. KGaACompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.Contact for media representatives:Michael FranzHead of Brand CommunicationP +49 (0) 261 8000-6100F +49 (0) 261 8000-3100E-mail: press@cgm.comContact for analysts and investors:Claudia ThoméCorporate Vice President Investor RelationsP +49 (0) 261 8000-7030F +49 (0) 261 8000-3200E-mail: claudia.thome@cgm.com15.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 7030 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1184966 End of News DGAP News Service

  • EQS Group

    CompuGroup Medical plans one billion Euro in revenue after record year

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Annual Results/Quarter Results04.02.2021 / 07:45 The issuer is solely responsible for the content of this announcement. 2020 fiscal year with revenues of EUR 837 million and adjusted EBITDA of EUR 215 million according to preliminary figures 12 % revenue increase compared to 2019, thereof 4 % organic Recurring revenues grow + 14 % versus prior year, now at 63 % of total revenues About 20 % increase in revenues to EUR 1 billion expected for 2021 Guidance for adjusted EBITDA in 2021 at EUR 210 million to EUR 230 million Significant investments planned in future growthKoblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading providers of eHealth solutions, has presented preliminary figures today for the fourth quarter and the 2020 fiscal year. The Koblenz-based company ended the full year with revenues of EUR 837 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 215 million, both fully in line with the increased guidance range communicated in August for 2020."The achievement of the guidance and by far the strongest year in the history of CGM are confirming our course. They underline the company's strong resilience in an extraordinary year. This is also reflected in the strong free cash flow," emphasizes Chief Financial Officer (CFO) Michael Rauch and adds: "The visibility will continue to be limited due to the corona virus situation. However, what we already can say is that we rather expect a stronger second half-year - similarly to the past fiscal year."Revenues of one billion Euro expectedFor the year 2021, CGM is planning another significant increase. For the fiscal year 2021, revenues within the range of EUR 1 billion to EUR 1.04 billion are expected. The adjusted EBITDA for 2021 is expected to be between EUR 210 million and EUR 230 million. Both major acquisitions contribute to this, which were completed in 2020 in the "hospitals" customer segment in Europe, on the one hand, and in the US market for Ambulatory Information Systems, on the other hand. For the current year, additional investments are planned in new technologies and in sales, to realize the many new growth opportunities resulting from the quickly advancing digitization of the healthcare system. Management intends to use these opportunities to create strong organic growth and attractive EBITDA margins in the following years.In light of the recent financial figures and the planned investments, Dr. Dirk Wössner, CEO of CompuGroup Medical since the beginning of January, is optimistic: "We intend to and will push forward with important future issues, such as interoperability, consumerization and datafication in healthcare, also through massive investments. Major growth opportunities will also result from this in the coming years. CGM intends to position itself optimally to take advantage of the increased efforts to digitize the healthcare system. We are convinced that these investments will already pay off in the near future."Positive performance in all segmentsIn its core business, CGM showed encouraging growth in all four segments. In the Hospital Information Systems (HIS) segment, revenues in the full year 2020 grew by 37 % to EUR 187 million, based on preliminary figures. The adjusted EBITDA in this segment grew by 65 % to EUR 32 million in comparison to the previous year. The strong increase is mainly attributable to the acquisition of parts of Cerner's portfolio in Germany and Spain. The laboratory area, which benefited significantly from the increased demand for laboratory services in connection with COVID-19, showed particularly positive performance.In the largest segment, Ambulatory Information Systems (AIS), revenues grew in the full year by 5 % to EUR 467 million. Recurring revenues in this segment grew by 8 % to EUR 330 million in the full year. The further rollout of the Telematics Infrastructure (TI) with electronic emergency data and electronic medication plans in German medical practices and the acquisition of Epsilog at the end of 2019 contributed to this.The Pharmacy Information Systems (PCS) segment increased revenues by 13 % in 2020 in comparison to the previous year, to a new level of EUR 135 million including TI. EBITDA increased by 18 % to EUR 38 million. In the PCS segment, through the approval of the eHealth Connector, the rollout of the Telematics Infrastructure (TI) in pharmacies was set into motion and contributed to an excellent revenue growth in the second half. Recurring revenues grew by 6 % in 2020 to EUR 76 million in comparison to the previous year.In the newest segment, Consumer and Health Management Information Systems (CHS), revenue growth was achieved of 5 % to EUR 48 million. This growth results from a positive development in the intermedix business area. For digital healthcare applications, new products have been developed in the past months, with which both doctors and patients can prescribe/use so-called "Apps on prescription" quickly and easily.The full quarterly report is available on the company's website at www.cgm.com/ir-publications. About CompuGroup Medical SE & Co. KGaACompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 837 million in 2020 based on preliminary figures, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.Contact for media representatives:Michael FranzHead of Brand CommunicationP +49 (0) 261 8000-6100F +49 (0) 261 8000-3100E-mail: press@cgm.comContact for analysts and investors:Claudia ThoméCorporate Vice President Investor RelationsP +49 (0) 261 8000-7030F +49 (0) 261 8000-3200E-mail: claudia.thome@cgm.com04.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 7030 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1165690 End of News DGAP News Service